| 5.03 Data as of May 17 |  +0.03 / +0.60%Today’s Change | 2.55 Today|||52-Week Range 6.25 | +40.11% Year-to-Date |
| Previous close | 5.00 |
| Today’s open | 5.05 |
| Day’s range | 4.91 - 5.05 |
| Volume | 114,984 |
| Average volume (3 months) | 224,559 |
| Market cap | $185.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +52.11% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +166.67% |
| P/E ratio | NM |
| Price/Sales | 2,440.02 |
| Price/Book | 7.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| CTIXCellceutix Corp | +0.06 | +3.08% |
| ACSTAcasti Pharma Inc | 0.00 | 0.00% |
| SUPNSupernus Pharmaceuti... | +0.16 | +2.74% |
| DRTXDurata Therapeutics ... | -0.01 | -0.14% |
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -23,186.09% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso, MBA |
Chief Operating Officer Joshua Disbrow, MBA |
Corporate headquarters Greenwood Village, Colorado |
.
